Ancillary income still under scrutiny, despite boost to Admiral profits

Admiral logo

After easing the pressure built up during a bodily injury claims-ravaged third quarter, bosses at Admiral have been warned that this year's hot topic of ancillary income could yet provide a sting in the tail.

Described by group chief operating officer David Stevens as "a year of two halves", the final quarter of 2011 saw a dramatic turnaround at the firm, not just in share price - which went from 815.5p

Only users who have a paid subscription or are part of a corporate subscription are able to print or copy content.

To access these options, along with all other subscription benefits, please contact info@postonline.co.uk or view our subscription options here: http://subscriptions.postonline.co.uk/subscribe

You are currently unable to copy this content. Please contact info@postonline.co.uk to find out more.

Sorry, our subscription options are not loading right now

Please try again later. Get in touch with our customer services team if this issue persists.

New to Insurance Post? View our subscription options

Register

Want to know what’s included in our free registration? Click here

Already have an account? Sign in here

This address will be used to create your account

Could rugby court clash shift the sport to self-insuring?

The outcome of a lawsuit launched by hundreds of rugby union players could have a far-reaching impact on the future of the sport. Tim Evershed looks at whether parallels can be drawn with similar actions in the US against governing bodies, such as the NFL and NHL, and what can be done to make sure players remain insurable.

Using AI to monitor claim health

Wayne Calderbank, group data and performance director at Claims Consortium Group, says artificial intelligence is enabling the monitoring of sentiment within the claims journey and ensuring potential problems can be identified and addressed.

You need to sign in to use this feature. If you don’t have an Insurance Post account, please register for a trial.

Sign in
You are currently on corporate access.

To use this feature you will need an individual account. If you have one already please sign in.

Sign in.

Alternatively you can request an individual account here